桥梁PROTAC,基于DNA的PROTAC和水标签技术用于向蛋白质降解
Pengcheng Gao1, Yue Zhong1, Kaixiu Luo1
1Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Science, Oncological Science and Neuroscience, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Advanced drug delivery reviews
|February 18, 2026
概括
化向基因组 (PROTACs) 提供了一种新的治疗方法,通过无素-蛋白酶系统降解向蛋白质. 新的PROTAC技术扩大了可治疗疾病的范围,通过向以前无法治疗的蛋白质.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白质解离向嵌合体 (PROTACs) 利用无素-蛋白酶体系统进行向蛋白质降解 (TPD).
- PROTACs以催化方式降解向蛋白质,与传统的抑制剂相比,它具有明显的优势.
- PROTAC技术已经显示出显著的治疗潜力,许多候选人在临床开发中.
研究的目的:
- 解决传统的PROTACs的局限性,这些PROTACs依赖于对感兴趣的蛋白质和E3结合酶的特定结合剂.
- 引入和讨论创新策略,扩大TPD可向蛋白质的范围.
- 为更广泛的治疗应用突出展示PROTAC技术的进步.
主要方法:
- 使用内源性蛋白质-蛋白质相互作用的桥梁 PROTACs 的开发.
- 基于DNA的PROTACs (TF-PROTACs) 的设计用于降解缺乏小分子结合口袋的转录因子.
- 基于水标签的降解剂 (HyTs) 的实施,以诱导蛋白质错误折叠和降解.
主要成果:
- 桥梁 PROTACs 能够准"不可抗药"蛋白质和尚未探索的 E3 连接酶.
- TF-PROTACs有效降低转录因子,扩展TPD到以前无法访问的目标.
- HyTs提供了口服生物可用性和通过蛋白质错误折叠的目标降解的潜力.
结论:
- 创新的 PROTAC 策略显著扩大了可向蛋白质的范围.
- 这些进展代表了针对性蛋白质降解领域的重大进步.
- 扩大PROTAC的功能有望增强对各种疾病的治疗发现.
相关概念视频
Tagging and Fusion Proteins
8.6K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.6K
The Proteasome
10.3K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.3K
The Proteasome
1.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.8K
Regulated Protein Degradation
9.0K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.0K
Tail-anchoring of Proteins in the ER Membrane
3.9K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.9K
The Proteasome Structure
1.9K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.9K


